PD-III participants exhibited impaired BBS (Fig 1A), TINETTI (Fig 1B), FRT (Fig 1C), and TUG (Fig 1D) scores relative to HC and PD-II (Table 2). This evidence concerns the gene BBS2 and Parkinson disease.